Field note · Life sciences

Country launch readiness

Regulatory approval is not the same as launch readiness. For a Swiss life-sciences company, each country launch is a commitment worth preparing properly.

3 min read

The situation

A Swiss life-sciences company has products approaching approval in several countries. Readiness varies: registration, local partners, supply, pricing and commercial capacity all move at different speeds.

The decision that matters

For each country, leadership decides whether to commit to a commercial launch, when, and with how much investment.

How we approach it

AI assembles the regulatory status, precedent from earlier country launches, and supply and partner readiness into a launch-readiness view for each market.

The launch owner sees what is genuinely ready, what is assumed and what each launch option would cost, before resources are committed.

Impact

The approach targets a single-digit million improvement in annual revenue from new markets.

More field notes

Field note · Engineered components

From design-in to series production

A Swiss maker of customer-specific components wins many design-in projects. Only some reach volume. Which ones deserve scarce engineering capacity?

3 min read Field note · Machine building

The major machine order

For a Swiss machine-tool builder, margin is set when a large order is accepted and made or lost in engineering and commissioning.

3 min read Field note · Industrial equipment

Turning a record order book into cash

A record backlog is good news, until components, production slots and specifications decide which orders actually turn into revenue.

3 min read

For the C-suite

Where could AI move your numbers?

We advise executive teams of Swiss enterprises on how to approach AI, where to invest, what to change first and how to measure it, and work alongside them to deliver the financial result. A first conversation is the quickest way to see where your largest opportunity lies.

Start a conversation